Clinical Evidence Compares Side Effect Profiles
Does Wegovy Have Less Side Effects Than Mounjaro: Clinical Trial Evidence
Clinical trials provide the most reliable evidence when comparing whether Wegovy has less side effects than Mounjaro. The STEP trials for Wegovy (semaglutide) and SURMOUNT trials for Mounjaro (tirzepatide) show remarkably similar side effect patterns, with gastrointestinal symptoms being the most commonly reported in both studies. Wegovy's mechanism as a GLP-1 receptor agonist affects appetite centres in the brain, whilst Mounjaro's dual GIP and GLP-1 receptor targeting may influence both glucose metabolism and satiety differently. Neither clinical trial programme demonstrates that one prescription-only medicine definitively has fewer side effects than the other, as individual patient responses vary significantly.
The question of whether Wegovy has less side effects than Mounjaro requires understanding that both medicines work by slowing gastric emptying, which naturally leads to similar gastrointestinal experiences during dose escalation. STEP 1 trial data shows approximately 84% of patients continued Wegovy treatment through the full study period, whilst SURMOUNT-1 shows similar completion rates for Mounjaro. Both medicines require careful dose escalation—Wegovy over 16 weeks to maintenance, Mounjaro over 20 weeks—to minimise side effects. Your prescriber at EverydayMeds (GPhC #9012878) can review your medical history to help determine which option may be more suitable for your individual circumstances.
Wegovy vs Mounjaro Pricing and Value Comparison
Understanding costs helps when evaluating whether Wegovy has less side effects than Mounjaro for your budget and treatment goals. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99 (weeks 1-4), progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg (£209.99). Our Getting Started bundles provide convenience for dose escalation—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Bundle options help manage the progression regardless of whether Wegovy has less side effects than Mounjaro in your experience. Our 3-pen Step-Up bundles include the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99, providing 12 weeks of initial escalation. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, ensuring consistent treatment once you reach your optimal dose. Take-It-Slow bundles like the Gentle Start Trio (two 0.25mg pens plus one 0.5mg) cost £269.99, perfect for patients who prefer extended time at lower doses to minimise side effects during escalation.
Comparing Side Effect Mechanisms: Why Individual Responses Vary
The question of whether Wegovy has less side effects than Mounjaro relates fundamentally to their different mechanisms of action, though both primarily affect the digestive system. Wegovy activates GLP-1 receptors exclusively, mimicking the natural incretin hormone that signals fullness and slows gastric emptying. Mounjaro targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, creating a dual incretin effect that may influence blood sugar and appetite through slightly different pathways.
Clinical evidence suggests these mechanistic differences don't dramatically change the overall side effect profile, meaning whether Wegovy has less side effects than Mounjaro depends more on individual patient factors than inherent drug differences. Both medicines most commonly cause nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation phases. The intensity and duration of these effects vary significantly between patients, influenced by factors including eating habits, dose escalation speed, and individual digestive sensitivity.
How Wegovy Works in Your Body
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking a hormone naturally produced in your intestines when you eat. Once injected weekly via the FlexTouch pen, semaglutide binds to GLP-1 receptors in your brain's appetite control centres, specifically the hypothalamus, reducing hunger signals and food cravings. The medicine also slows gastric emptying, meaning food stays in your stomach longer, promoting feelings of fullness after smaller meals. This dual action—appetite suppression and enhanced satiety—works alongside reduced-calorie diet and increased physical activity to support sustainable weight management. Clinical trials like STEP 1 demonstrated these mechanisms helping patients achieve meaningful weight loss when combined with lifestyle modifications, though individual results vary. The once-weekly injection schedule helps maintain consistent semaglutide levels, providing continuous appetite regulation support throughout your treatment journey.
Professional Assessment and Ordering Process
Determining whether Wegovy has less side effects than Mounjaro for your situation begins with our 3-minute online clinical assessment, where you'll answer questions about your medical history, current medications, and weight management goals. Our prescribing team reviews your assessment within 3 working days (or 24 hours with express service), evaluating factors that might influence side effect risk or treatment suitability. Once approved, your prescription-only medicine ships via next-day delivery using cold-chain temperature-controlled packaging to ensure product integrity. Our GPhC-registered pharmacy (GPhC #9012878) maintains strict quality standards throughout the dispensing and delivery process. Follow-up support includes access to our clinical team for dose adjustment guidance and side effect management advice as you progress through your treatment journey.
Storage Advantages and Practical Considerations
Storage requirements may influence your choice when considering whether Wegovy has less side effects than Mounjaro, particularly if you travel frequently or have limited refrigeration access. Wegovy offers superior storage flexibility, remaining stable for 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medicines require refrigerated storage (2-8°C) before first use, but Wegovy's extended room temperature stability provides practical advantages for work trips, holidays, or lifestyle flexibility. The FlexTouch pen design delivers consistent doses with audible and tactile confirmation, whilst the dose escalation schedule (0.25mg to 2.4mg over 16 weeks) allows gradual adjustment to minimise side effects. Proper storage and injection technique, detailed in the patient information leaflet, help ensure optimal treatment outcomes regardless of which medicine you choose.
Individual Response Factors: Beyond the Clinical Trials
Real-world experience often differs from clinical trials when determining whether Wegovy has less side effects than Mounjaro for individual patients. Factors including your baseline eating patterns, stress levels, concurrent medications, and digestive health history all influence how your body responds to either treatment. Some patients find Wegovy's single-target GLP-1 action more predictable, whilst others prefer Mounjaro's dual-receptor approach for its potentially different metabolic effects.
The timing of side effects also varies individually—some patients experience initial nausea that resolves within 2-3 weeks, whilst others find symptoms fluctuate with dose increases throughout escalation. Neither clinical evidence nor patient reports consistently demonstrate that Wegovy has less side effects than Mounjaro across all populations, reinforcing the importance of medical supervision and personalised treatment planning. Your prescriber can adjust escalation timing, provide side effect management strategies, and switch between treatments if needed to optimise your weight management journey.
Make Your Choice: Both Available From EverydayMeds
Rather than definitively answering whether Wegovy has less side effects than Mounjaro, the evidence suggests both prescription-only medicines offer similar overall tolerability with individual variation being the key factor. EverydayMeds provides access to both treatments through the same streamlined process—complete your clinical assessment, receive prescriber review, and get next-day cold-chain delivery once approved. New customers use code FIRST40 at checkout, whilst returning customers apply DOSE25 for discounted pricing. Our clinical team (GPhC #9012878) remains available throughout your treatment to discuss side effect management, dose adjustments, or switching between medications if your initial choice doesn't suit your needs. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your assessment and let our prescribers help determine whether Wegovy or Mounjaro aligns better with your weight management goals and medical profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
